S&P Global Market IntelligenceDiscover more about S&P Global’s offerings
Investor RelationsProduct Login
Obtain the data you need to make the most informed decisions by accessing our extensive portfolio of information, analytics, and expertise. Sign in to the product or service center of your choice.Customer Logins
Europe and the UK have experienced an uneven rollout of vaccines. In today’s episode, our country risk and life science experts come together to talk about supply chain challenges, heightened protectionist moments, enhanced regulatory reviews, and even strange vaccine bedfellows as some countries turn to Russia’s Sputnik vaccine to push along herd immunity.
Learn more additional risk to vaccine rollouts:
Vaccine hesitancy boosts risks from vaccine nationalism
The risks of vaccine nationalism
SUBSCRIBE: Apple | Stitcher | Spotify | RSS | Google Play